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ABSTRACT 
Our previous reports indicate that ligand-induced   αVβ3 integrin and Syndecan-4 
engagement increases focal adhesion formation and migration of astrocytes. Additionally, 
ligated integrins trigger ATP release through unknown mechanisms, activating P2X7 
receptors (P2X7R), and the uptake of Ca2+ to promote cell adhesion. However, whether the 
activation  of  P2X7R  and  ATP  release  are  required  for  astrocyte  migration  and  whether  αVβ3 
integrin and Syndecan-4 receptors communicate with P2X7R via ATP remains unknown. 
Here, cells were stimulated with Thy-1,   a   reported  αVβ3 integrin and Syndecan-4 ligand. 
Results obtained indicate that ATP was released by Thy-1 upon integrin engagement and 
required the participation of phosphatidylinositol-3-kinase (PI3K), phospholipase-C gamma 
(PLCγ) and inositol trisphosphate (IP3) receptors (IP3R). IP3R activation lead to increased 
intracellular Ca2+, hemichannel (Connexin-43 and Pannexin-1) opening, and ATP release. 
Moreover, silencing of the P2X7R or addition of hemichannel blockers precluded Thy-1-
induced astrocyte migration. Finally, Thy-1 lacking the integrin-binding site did not 
stimulate ATP release, whereas Thy-1 mutated in the Syndecan-4-binding domain 
increased ATP release, albeit to a lesser extent and with delayed kinetics compared to wild-
type Thy-1. Thus, hemichannels activated downstream of an αVβ3 integrin-PI3K-PLCγ-
IP3R pathway are responsible for Thy-1-induced, hemichannel-mediated and Syndecan-4-
modulated ATP release that transactivates P2X7Rs to induce Ca2+ entry. These findings 
uncover a hitherto unrecognized role for hemichannels in the regulation of astrocyte 
migration via P2X7R transactivation induced by integrin-mediated ATP release. 
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Abbreviations 
2-aminoethoxydiphenyl borate (2-APB); adenosine 5’-triphosphate (ATP); Brilliant Blue G 
(BBG); ethylene glycol tetraacetic acid (EGTA); endoplasmic reticulum (ER); extracellular 
matrix (ECM); focal adhesions (FAs); focal adhesion kinase (FAK); fetal bovine serum 
(FBS); fibroblast growth factor (FGF); heparin-binding domain (HBD); inositol 
trisphosphate (IP3); IP3 receptors (IP3R); P2X7 receptors (P2X7R); phosphate-buffered 
solution (PBS); phosphatidylinositol-3-kinase (PI3K), phospholipase-C gamma (PLCγ); 
protein kinase C-alpha (PKCD Rho-associated kinase (p160ROCK); standard error of the 
mean (s.e.m.). 
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1. INTRODUCTION 
Integrins are heterodimers of D and E subunits, both of which contain short intracellular 
domains that lack enzymatic activity and interact with many enzymes, scaffolding proteins, 
and adaptors to form large protein complexes known as focal adhesions (FAs) [1, 2]. FAs 
are elongated structures that connect the extracellular matrix (ECM) proteins to the 
cytoskeleton via integrins [3] and thereby mediate cell adhesion to the ECM, an essential 
event for cell migration [4-6]. 
Migration is a cyclic process that involves cell polarization, membrane protrusion at 
the leading edge, FA and stress fiber formation, cell contraction, and retraction of the 
trailing edge to allow cells to move forward [4, 7]. Strong cell adhesion through FAs 
reduces migration, whereas increased turnover of FAs enhances cell motility. From data 
available on the composition of the integrin adhesome, a database that has mapped the 
interactions between 180 or more proteins present in integrin signaling complexes [8, 9], it 
is clear that many receptors and signaling proteins control cell adhesion and migration. One 
of these proteins is the transmembrane proteoglycan, Syndecan-4, which is involved in 
promoting anchorage to ECM substrates [10] and binding to other cells [11]. Additionally, 
in fibroblasts, the binding of Syndecan-4 to fibronectin allows the association of Syndecan-
4 with protein kinase C-alpha (PKCD, which activates RhoG and triggers endocytosis of 
E1 integrin and increased FA turnover [12]. Thus, Syndecan-4 has been suggested to 
regulate the transition from strong cell adhesion to cell migration.  
Our results indicate that the neuronal glycoprotein Thy-1 interacts with both DVE3 
integrin and Syndecan-4 in astrocytes to promote cell adhesion and migration. Ligand-
AC
CE
PT
ED
 M
AN
US
CR
IPT
ACCEPTED MANUSCRIPT
  
 5 
receptor interactions occur through two different domains of the Thy-1 protein: 1) a region 
containing the arginine-leucine-aspartic acid (RLD) tripeptide, and 2) a heparin-binding 
domain (HBD), respectively [11, 13, 14]. Other reports have also confirmed such ligand-
receptor binding [15-17]. Thy-1–integrin/Syndecan-4 interactions increase astrocyte 
adhesion to the ECM [11] and require the recruitment and aggregation of DVE3 integrin. 
Integrin clustering activates focal adhesion kinase (FAK), Rho-associated kinase 
(p160ROCK), and RhoA [18]. Integrin signaling also involves PKCD, and possibly inositol 
trisphosphate (IP3) receptor (IP3R) activation because IP3R inhibitors reduce RhoA 
activity and astrocyte adhesion induced by Thy-1 [11]. Moreover, prolonged Thy-1 
stimulation induces the polarization and migration of DITNC1 astrocytes via the activation 
of FAK, phosphatidylinositol-3-kinase (PI3K), and the small GTPase Rac1 [19]. 
Strong astrocyte adhesion induced by Thy-1 also requires increased extracellular 
adenosine 5’-triphosphate (ATP), activation of the purinergic P2X7 receptor (P2X7R), and 
Ca2+ entry into the cell [20]. Whether this molecular mechanism is also required for cell 
migration and how ATP is released from the cells to the extracellular media are questions 
that remain to be explored. Moreover, how these molecular events temporarily connect to 
the integrin-induced signaling pathways requires further studies.  
Under physiological conditions, two general mechanisms for ATP release have been 
proposed. The first one is exocytic [21, 22] and the second one involves the hemichannel 
proteins [23-30], connexins or pannexins, which are present in astrocytes [31, 32]. 
Connexin hemichannels are well-established gap junction constituents that allow individual 
cells to communicate with the extracellular medium by permitting the passage of a variety 
of molecules, such as sugars, small peptides, glutamate, and ATP [33-36]. Pannexins are 
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transmembrane channels that, like connexins, participate in the liberation of ATP and other 
small molecules through the plasma membrane. Likewise, pannexins also form gap 
junctions in vitro [29, 37, 38]. Interestingly, through the release of ATP, hemichannels are 
known to participate in cell migration events. In fibroblasts, the C-terminal domain of 
Connexin-43 can interact with and modify tubulin and cytoskeletal dynamics [39]. 
Furthermore, Connexin-43 also impacts on cell polarity [39]. In astrocytes, Connexin-43 is 
required for cell migration under pro-inflammatory conditions and it interacts with many 
cytoskeletal  proteins,  such  as  β-actin and glial fibrillary acidic protein [40, 41]. Conversely, 
pannexins regulate motility of different cell types, such as neutrophils or leucocytes, tumor 
cells, venous fibroblasts, and neurons, among others [42-44]. Given these observations, we 
evaluated whether these hemichannels participate in Thy-1-induced migration of astrocytes 
by mediating ATP release and P2X7R activation.   
Here we show that P2X7R activation is important for cells to migrate in response to 
Thy-1. Additionally, both Connexin-43 and Pannexin-1 participate in Thy-1-induced ATP 
release downstream of DVE3 integrin, leading to P2X7R transactivation. We also provide 
evidence demonstrating that after Thy-1 stimulation, hemichannel opening is modulated by 
Syndecan-4 and requires PI3K/phospholipase C gamma (PLCJ-mediated IP3R activation, 
which leads to the subsequent release of Ca2+ from intracellular stores. Together, these 
findings reveal a novel mechanism linking integrin function to P2X7R transactivation and 
astrocyte migration via ATP release through hemichannels. 
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2. RESULTS 
2.1. The P2X7 receptor is required for Thy-1-induced astrocyte polarization and 
migration 
We previously demonstrated that the P2X7R is required to increase Ca2+ uptake and cell 
adhesion to the underlying matrix [20]. Here, we set out to study whether P2X7R is also 
required for Thy-1-stimulated migration of astrocytes. We observed that incubation of 
DITNC1 astrocytes with the nucleotidase enzyme, Apyrase, precluded Thy-1-induced 
migration (Fig. 1A), indicating a requirement for ATP. We then tested the effects of 
different BzATP concentrations (0.1, 1, 5, 10, and 100 PM) on cell migration. BzATP, a 
non-hydrolyzable ATP analogue, was found to induce cell migration at 10 and 100 PM 
(control vehicle, 1.0 ± 0.04; [BzATP] = 10 PM, 1.37 ± 0.05, p < 0.05; [BzATP] = 100 PM, 
1.6 ± 0.1, p < 0.001). The latter concentration was used in subsequent experiments (unless 
indicated otherwise) and coincides with that employed in our previous study [20]. 
Moreover, migration stimulated by either Thy-1-Fc fusion protein or BzATP was inhibited 
by two P2X7R antagonists, Brilliant Blue G (BBG) and A438079 (Fig. 1A). The negative 
control for the Fc-portion of the Thy-1 fusion proteins used in these experiments (Trail-R2-
Fc; see Methods) behaved similarly to the control with serum-free medium (Fig. 1A).  
To confirm the role of the P2X7R in wound closure, cell migration was evaluated 
following knockdown of this receptor. Importantly, the siRNA for P2X7R used in these 
experiments decreases P2X7R mRNA levels without affecting the mRNA levels of other 
P2X receptors [20]. Here, we demonstrate that diminished P2X7R protein levels (Fig. 1B, 
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insert) blocked migration of astrocytes induced by Thy-1-Fc but had no effect on Trail-R2-
Fc-treated cells (Fig. 1B).  
The role of P2X7R was also tested in a cell polarization assay. Reorientation of the 
Golgi apparatus towards the leading edge was evaluated as previously described [19, 45]. 
The increased number of polarized DITNC1 cells induced by either Thy-1-Fc or BzATP 
was reduced by BBG and A438079 (Fig. 1C). Therefore, P2X7R-mediated events required 
for astrocyte adhesion to the underlying matrix [20] are also essential for cell polarization 
and migration induced by Thy-1. 
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Figure 1. ATP-activated P2X7 receptor is required for Thy-1-induced astrocyte migration 
and polarization.  
Wounded monolayers of cells were treated as indicated below in serum-free medium. A) 
Representative microphotographs of cells migrating in a wound-healing assay are shown. 
Cells in a wounded monolayer at time 0 and 24 h are shown in green and red, respectively 
(virtual colors). The graph shows the quantitative analysis of cell migration after 24 h. Non-
treated DITNC1 astrocytes (control) or astrocytes previously treated with vehicle 
(phosphate-buffered solution; PBS), BBG (5 PM), Apyrase (3 U/ml) or A438079 (100 nM). 
Where indicated, astrocytes were treated with Trail-R2-Fc (negative control), Thy-1-Fc or 
BzATP (100 PM) for 24 h. Values of wound closure were obtained by estimating the cell-
free area at 0 and 24 h. Wound closure (fold-increase) was calculated as a ratio of the 
values obtained for every sample divided by those obtained for the non-stimulated samples 
(control in serum-free medium). Values are expressed as means ± s.e.m. B) Cells 
transfected with siRNA against P2X7R or a control siRNA were stimulated with the 
indicated treatments, and wound closure was determined and shown as indicated in A. 
Insert in the graph shows decreased P2X7R protein levels upon appropriate siRNA 
treatment. C) Cell polarization assay of DITNC1 astrocytes treated with vehicle, BBG, or 
A438079 and then treated with Trail-R2-Fc, Thy-1-Fc, or BzATP for 7 h. Schematic 
representation of polarized cells (top left panel) with Golgi (green) oriented within a 120º 
angle (blue dashed lines) towards the wounded area (right of the red dashed line) and 
positioned in front of the nucleus (blue). Representative microphotographs of polarized 
(marked as 1) and non-polarized (marked as 2) cells with the different treatments are 
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shown. Values in the graph represent means ± s.e.m. of the quantifications obtained as the 
percentage of polarized cells. Only the first two rows of cells at the wound border were 
counted. **, p < 0.01; ***, p < 0.001, evaluated from three independent experiments. 
 
2.2. Thy-1 induces ATP release and cell migration dependent on integrin and Syndecan-
4 engagement 
To investigate the mechanism involved in ATP release upon Thy-1 addition, extracellular 
ATP was measured at different time points following the stimulation of astrocytes with 
various previously described Thy-1 mutants [11, 13]. First, SDS-PAGE and Coomassie 
Blue staining were employed to assess the quality of the Thy-1 mutants. The results 
revealed the presence of a single band in all cases (Fig. 2A). In addition, Thy-1-Fc induced 
astrocyte migration, whereas neither the single-domain Thy-1 mutated molecules [Thy-
1(RLE)-Fc or Thy-1(AEAAA)-Fc] nor the double mutant [Thy-1(RLE/AEAAA)-Fc] 
induced astrocyte migration[19] (Fig. 2A, bottom panel). Moreover, to demonstrate the 
functionality of different Thy-1 proteins, single domain mutants were combined and 
migration was then evaluated. When both mutant proteins were added in combination, the 
increase in migration observed was similar to the effect obtained with the wild-type Thy-1-
Fc molecule (Fig. 2A, bottom panel), indicating that the individual mutations did not 
disrupt the Thy-1 structure.  
Subsequently, ATP levels were measured upon treating astrocytes with each of the four 
different Thy-1 molecules. Thy-1 mutated in the HBD [Thy-1(AEAAA)-Fc] (Fig. 2B, 
squares) led to a delayed release of less ATP compared to non-mutated Thy-1-Fc protein 
(Thy-1-(RLD)-Fc; Fig. 2B, circles). Upon stimulation of astrocytes with Thy-1 mutated in 
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the integrin-binding domain [Thy-1(RLE)-Fc], which possesses an intact HBD that permits 
binding to Syndecan-4, no changes in extracellular ATP levels were observed (Fig. 2B 
upright triangles). In addition, Thy-1 mutated in both binding sites [Thy-1(RLE/AEAAA)-
Fc] did not result in ATP release (Fig. 2B, inverted triangles). These findings, together with 
results indicating that BzATP added at concentrations >10 µM suffice to induce cell 
migration (Fig. 1A), led us to hypothesize that the molecular changes leading to ATP 
release in Thy-1-stimulated DITNC1 cells are triggered by DVE3 integrin engagement, 
whereas signaling pathways downstream of Syndecan-4 do not trigger ATP release, but 
rather appear necessary to modulate integrin-induced ATP release. To test this hypothesis, 
cells were treated with BzATP at suboptimal concentrations (<10 µM) in conjunction with 
either Thy-1(RLE)-Fc or Thy-1(AEAAA)-Fc. Neither BzATP added at 0.1 or 1 µM nor the 
mutants added individually stimulated cell migration (Fig. 2B, 2C). Moreover, low BzATP 
concentrations, added with Thy-1-Fc, which binds integrin only [Thy-1(AEAAA)-Fc], did 
not affect cell migration (Fig. 2C). However, BzATP added simultaneously with mutated 
Thy-1-Fc, which only binds through the HBD [Thy-1(RLE)-Fc], induced cell migration 
(Fig. 2D).  
To provide direct evidence for the participation of DVE3 integrin, and Syndecan-4 as Thy-1 
receptors involved in ATP release, we then silenced either E3 integrin, or Syndecan-4 and 
measured ATP release upon Thy-1 addition. Non-transfected cells or cells transfected with 
scramble siRNA increased extracellular levels of ATP when stimulated with Thy-1 (Fig. 
2E). The extent of ATP release did not change significantly in cells stimulated following 
transfection with integrin- or Syndecan-4-targeting siRNA (Fig. 2E). Importantly, these 
results were similar to those obtained with Thy-1 mutated in the HBD (Fig. 2B). 
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Altogether, the results indicate that Thy-1 binding to DVE3 integrin leads to ATP release, 
but that optimal levels are attained following the interaction of Thy-1 with both receptors. 
This suggests that Syndecan-4 engagement provides a positive feedback loop necessary to 
reach threshold ATP levels required for astrocyte migration. 
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Figure 2. Thy-1 induces ATP release and wound closure in an integrin-dependent 
manner.  
A) Quantitative analysis of DITNC1 astrocyte migration upon treatment with the different 
Thy-1-Fc mutants for 24 h. Bands in the gel correspond to the 5 different Fc fusion proteins 
used in this study: (1) Trail-R2-Fc, (2) Thy-1-Fc, (3) Thy-1(RLE/AEAAA)-Fc, (4) Thy-
1(AEAAA)-Fc and (5) Thy-1(RLE)-Fc. Wound closure was estimated upon treatment with 
these Fc proteins as indicated in figure 1A. (RLE)+(AEAAA)-Fc (4+5) indicates cells 
treated with both mutated Thy-1 proteins together. B) DITNC1 astrocytes were stimulated 
with the different Thy-1-Fc mutants and at the indicated time points ATP was measured in 
supernatants. Values in the graph represent means ± s.e.m. from four independent 
experiments. C-D) Wound closure assay of cells stimulated simultaneously with 0.1 or 1 
µM of BzATP and Thy-1(AEAAA)-Fc (C) or Thy-1(RLE)-Fc (D) for 24 h. BzATP (100 
µM) was used as a positive control. E) Integrin subunit E3 or Syndecan-4 were silenced by 
transfection of DITNC1 cells with siRNA targeting these receptors. Cells transfected with a 
scrambled siRNA provided by the manufacturer were used (see Methods section) as a 
control. After 48 h of recovery and 30 min in serum-free medium containing nuclease 
inhibitor, cells were stimulated with Thy-1-Fc (or TRAIL-R2-Fc as negative control) and 
ATP release was evaluated. *, p < 0.05; **, p < 0.01; ***, p <0.001 calculated from three 
independent experiments. Error bars are s.e.m. 
 
2.3. Thy-1 induces ATP release through Connexin-43 and Pannexin-1 hemichannels. 
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To gain further insight into the mechanism of ATP release, extracellular ATP was 
monitored after stimulating the astrocytes with Thy-1 in the presence or absence of two 
Golgi-perturbing agents, Bafilomycin A and Brefeldin A [46]. These agents did not affect 
Thy-1-induced ATP release, indicating that exocytosis is not relevant for this process (Fig. 
3A).  
ATP release to the extracellular space in response to various stimuli also occurs 
through connexin/pannexin hemichannels [31]. To assess whether these hemichannels 
participate in Thy-1-induced ATP release, several hemichannel blockers were tested. The 
pannexin inhibitor, Probenecid, and the connexin inhibitor, Heptanol, decreased 
extracellular ATP levels individually, but residual levels were still higher than those 
observed in the negative controls. However, a combination of both inhibitors reduced ATP 
levels to those observed in controls (Fig. 3A). To obtain direct evidence for hemichannel 
opening, we performed a dye uptake assay using the low molecular weight fluorescent dye, 
Lucifer Yellow, a membrane impermeable molecule that can only be taken up by cells upon 
the opening of hemichannels [31, 47]. As expected, Thy-1-induced Lucifer Yellow uptake 
was inhibited by Probenecid and Heptanol as well as a combination of both inhibitors (Fig. 
3B).  
The principal hemichannels in astrocytes are Pannexin-1 and Connexin-43 [48, 49]. 
Therefore, the existence of these proteins in non-junctional areas of DITNC1 cells was first 
confirmed by Western blot analysis (Fig. 3C). The bands observed are similar to those 
detected in primary astrocytes and the human embryonic kidney 293T cells used as controls 
(Fig. 3C). Immunofluorescence assays performed on cells at low confluency revealed that 
both Connexin-43 and Pannexin-1 were detectable at non-junctional cell borders, indicative 
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of an hemichannel configuration (Fig. 3D). We then confirmed the results by using more 
specific astrocyte hemichannel blockers. Pannexin-1 was blocked with the peptides, 
10panx1 and E1b [31, 47, 50], which recognize the extracellular loop domain of Pannexin-
1, while Connexin-43 was inhibited with the blocking peptides, Gap26 and Gap27 [31, 47]. 
When used individually, these peptides partially repressed the increase in extracellular ATP 
(Fig. 3E) and Lucifer Yellow uptake (Fig. 3F) stimulated by Thy-1. However, as observed 
previously with Probenecid and Heptanol, the combination of both connexin- and 
pannexin-blocking peptides completely abolished Thy-1-induced ATP release (Fig. 3E) as 
well as dye uptake (Fig. 3F). 
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Figure 3. Thy-1 induces ATP release through Connexin-43 and Pannexin-1 
hemichannels.  
A) ATP values after 10 min of Thy-1 addition were determined in the supernatants of 
cultured cells previously incubated for either 30 min with Heptanol (500 PM), Probenecid 
(1 mM), or a combination of both inhibitors, or 4 h with the exocytosis inhibitors, 
Brefeldine A (3 Pg/ml) or Bafilomycin A (1 PM). Cells were then treated with Thy-1 or 
Trail-R2-Fc (negative control). B) Lucifer Yellow uptake in DITNC1 cells treated with 
Trail-R2-Fc, stimulated with Thy-1-Fc for 10 min, or treated with the indicated inhibitors 
for 30 min prior to Thy-1 addition. Values in the graph are mean fluorescence intensity 
normalized to the non-stimulated condition. C) Cell lysates of DITNC1 cells, primary 
astrocytes, and HEK293T cells were immunoblotted for Connexin-43, Pannexin-1, and 
HSP90 as a loading control. Proteins are indicated to the right of the panels. P0, P1 and P2 
correspond to multiple electrophoretic forms of the Connexin-43 [51]. D) DITNC1 cells 
were fixed and permeabilized prior to staining. Hemichannel presence was evaluated by 
immunofluorescence using anti-Connexin-43 and anti-Pannexin-1 antibodies followed by 
the corresponding secondary antibodies (green and red, respectively). Nuclei were stained 
with DAPI (blue). E) Extracellular ATP levels in cells treated with Trail-R2-Fc or Thy-1-Fc 
for 10 min after treating with vehicle (0.001% DMSO/PBS); the Pannexin-1-blocking 
peptides, 10panx1 (100 PM) and E1b (100 PM); the Connexin-43-blocking peptides, 
Gap26 (300 PM) and Gap27 (300 PM); or a mixture of 10panx1 and Gap27 for 30 min. F) 
Lucifer Yellow uptake in cells stimulated with Trail-R2-Fc or Thy-1-Fc for 10 min and 
previously treated with the indicated hemichannel-blocking peptides for 30 min. Values 
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shown in all graphs are the means ± s.e.m. from four independent experiments. *, p < 0.05; 
**, p < 0.01; ***, p < 0.001. 
 
2.4. Thy-1-induced ATP release through hemichannels requires intracellular calcium 
release through IP3 receptor channels 
Our results suggest that, upon Thy-1 stimulation, integrin-dependent signaling pathways 
lead to ATP release via both types of hemichannels (Fig. 3) and that Ca2+ influx depends on 
the activation of the P2X7R [20]. Thus, we expected hemichannel blockers to inhibit 
intracellular Ca2+ increase. To evaluate this possibility, Ca2+ levels were tested in cells 
following Thy-1 stimulation in the presence or absence of the hemichannel blockers. 
Probenecid and Heptanol as well as a combination of both partially reduced Thy-1-induced 
[Ca2+]i increase after 5 min of stimulation (Fig. 4A), suggesting that Ca2+ increase is not 
only attributable to extracellular influx, but that it also depends on Ca2+ release from 
intracellular stores.  
Because ATP release induced by Thy-1 was efficiently blocked by the presence of 
Probenecid/Heptanol (Fig. 3A), the possibility that the remaining Ca2+ signal stems from 
P2X7R activation seemed rather unlikely. To identify other possible Ca2+ sources, different 
strategies were employed. As expected, when Ca2+-free medium supplemented with 
ethylene glycol tetraacetic acid (EGTA, a Ca2+ chelator) was employed, residual levels of 
intracellular Ca2+ were similar to those described above (Fig. 4B, blue triangles, compare to 
Fig. 4A, red diamonds). Alternatively, chelation of intracellular Ca2+ with the cell 
permeable BAPTA-acetoxymethyl ester (BAPTA-AM) reduced [Ca2+]i to non-stimulated 
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levels (Fig. 4B). Importantly, the IP3R inhibitors, 2-aminoethoxydiphenyl borate (2-APB) 
and Xestospongine B (Xestosp B), almost completely eliminated intracellular Ca2+ levels 
(Fig. 4C), whereas Ryanodine did not alter Thy-1-stimulated Ca2+ increases (Fig. 4C) when 
used at concentrations known to inhibit the intracellular Ryanodine receptor Ca2+ channel 
[52]. These results indicate that, following Thy-1 stimulation, intracellular Ca2+ levels are 
regulated by both influx from the extracellular medium and release from intracellular 
stores. In addition, intracellular Ca2+ release requires IP3R but not Ryanodine receptor 
activation. 
To confirm the importance of this Thy-1-induced Ca2+ release, additional Lucifer 
Yellow uptake and ATP release assays were performed in the presence of the different 
inhibitors described above. As for the Ca2+ signal, BAPTA-AM, 2-APB, and 
Xestospongine B prevented Lucifer Yellow uptake (Fig. 4D) and ATP release (Fig. 4E), 
whereas this was not the case in the presence of Ryanodine or Ca2+-free medium (Fig. 4D, 
4E). Lucifer Yellow uptake occurs in medium lacking calcium because this condition opens 
hemichannels [21, 53], and accordingly, ATP release was observed in Ca2+-free medium 
(Fig. 4E). To test whether Xestospongine B directly modulated hemichannels, the effect of 
this IP3R inhibitor was tested in Ca2+-free medium. We found that hemichannels opened in 
medium without Ca2+ even in the presence of Xestospongine B (Fig. 4F), demonstrating 
that Xestospongine-mediated inhibition was specific for IP3R-dependent Ca2+ release and 
did not affect hemichannel function per se. Therefore, we then tested whether the source of 
IP3 that activated the IP3R was due to PLCJ activation. As expected, U73122-mediated 
PLCJ inhibition precluded ATP release induced by Thy-1-Fc in DITNC1 astrocytes (Fig. 
4G). Additionally, given that LY294002-mediated inhibition of PI3K also reduced ATP 
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release (Fig. 4G), we reasoned that ATP release requires PI3K activation. Taken together, 
these observations suggest that Thy-1 induces PLCJ- and PI3K-dependent release of Ca2+ 
via IP3Rs to allow hemichannel opening, which leads to subsequent ATP release into the 
medium. 
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Figure 4. Intracellular Ca2+ is required for Thy-1-induced ATP release.  
Changes in the intracellular fluorescence of DITNC1 astrocytes loaded with Fluo4-AM 
were followed every 2 s. A) Representative microphotographs taken at 12 min and the 
quantification of intracellular Ca2+ kinetics of DITNC1 astrocytes are shown after 
stimulation with Thy-1-Fc (green circles) or stimulation following treatment with Heptanol 
(500 PM, blue triangles), Probenecid (1 mM, black squares) or a combination of both 
inhibitors for 30 min (red diamonds). B) Intracellular Ca2+ kinetics in DITNC1 astrocytes 
stimulated with Thy-1-Fc and pre-treated with BAPTA-AM (5 PM for 1 h) or Ca2+-free 
medium (Ca2+-FM). C) Intracellular Ca2+ kinetics of cells stimulated with Thy-1-Fc and 
previously treated with 2-APB (5 PM for 1 h), Ryanodine (50 PM for 4 h), or 
Xestospongine B (5 PM for 4 h). Individual points shown in the graphs correspond to the 
means ± s.e.m. from three independent experiments. D) Quantification of Lucifer Yellow 
uptake of DITNC1 astrocytes treated as in B and C. E) Measurement of extracellular ATP 
in DITNC1 astrocytes treated as in B and C. F) Lucifer Yellow uptake in DITNC1 
astrocytes treated with Xestospongine (5 PM) in complete medium or in Ca2+-free medium 
(Ca2+-FM). G) Measurement of extracellular ATP in DITNC1 astrocytes treated with Thy-
1-Fc in the presence of a PLC inhibitor (U73122, 10 PM for 30 min) or a PI3K inhibitor 
(LY294002, 10 PM for 1 h). ***, p < 0.001, estimated from three independent experiments. 
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2.5. ATP released by hemichannels is required for Thy-1-induced cell adhesion, 
polarization, and migration 
As shown previously [20] and in this study, Thy-1-induced P2X7R activation in DITNC1 
cells is required to increase cell adhesion, polarization, and migration (Fig. 1). To define the 
importance of ATP release via hemichannels in these processes, the effects of hemichannel 
blockers were tested in Thy-1-stimulated astrocytes. The Thy-1-enhanced number of FAs 
was completely blocked by either Probenecid or Heptanol, and no differences in the 
number of these structures were observed when cells were treated simultaneously with both 
inhibitors (Fig. 5A, 5B). Individually, these inhibitors also prevented the Thy-1-stimulated 
increase in FA area, while simultaneous treatment with both inhibitors decreased the size of 
these structures (Fig. 5A, 5C). Alternatively, although both compounds reduced astrocyte 
polarization (Fig. 5D) and migration (Fig. 5E) individually, complete inhibition was only 
achieved when the two reagents were combined. These results indicate that Thy-1 induces 
ATP release through the opening of both pannexin and connexin hemichannels, which 
contribute to Thy-1-induced cell adhesion, polarization, and migration. 
 Because cell migration assays are performed with confluent cell monolayers, we 
wanted to discard any possible contribution from Connexin-43-formed gap junctions. 
Therefore, we performed the wound-healing assay in the presence of a specific inhibitor of 
Connexin-43 hemichannels at a concentration greater than the described IC50, which does 
not affect gap junctions in astrocytes [54, 55]. As observed with Probenecid and Heptanol, 
Gap19 and Gap27 partially inhibited cell migration while simultaneous addition of Gap19 
and Panx10 blocked cell migration to basal levels (Fig. 5F). The scrambled peptide used as 
a control had no effect on migration induced by Thy-1 addition. 
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Figure 5. Thy-1-induced Pannexin-1 and Connexin-43 hemichannel opening is required 
for astrocyte adhesion, polarization, and migration.  
DITNC1 astrocytes were stimulated for different periods of time with Thy-1-Fc or treated 
with Trail-R2-Fc as a control. Where indicated, astrocytes were pre-treated for 30 min with 
Heptanol (500 PM) or Probenecid (1 mM). A) Representative microphotographs of FAs in 
DITNC1 astrocytes stimulated with Thy-1-Fc with or without prior treatment for 30 min 
with Heptanol or Probenecid or treated with Trail-R2-Fc for 15 min. Cells were fixed and 
stained with anti-vinculin and secondary anti-rabbit IgG antibody conjugated to FITC 
(green), rhodamine-conjugated Phalloidin (red), and DAPI (blue). Magnification bar = 15 
µm. B-C) Quantification of the FA number per cell (B) and average area of FAs (C) 
observed in DITNC1 astrocytes after the indicated treatments. Values in the graphs 
represent the means ± s.e.m. determined from at least 50 cells in each experimental 
condition per experiment using the “Analyze   particles”   function   in   ImageJ.   D)   Cell  
polarization assay of DITNC1 astrocytes stimulated with Thy-1-Fc or Trail-R2-Fc for 7 h 
with or without pretreatment with inhibitors as indicated in A. E) Wound-healing assay of 
DITNC1 astrocytes treated with Thy-1-Fc or Trail-R2-Fc for 24 h with or without prior 
treatment with inhibitors as indicated in A. F) Scratch assay of DITNC1 cells stimulated as 
in E, but pre-treatment was performed with vehicle (0.001% DMSO/PBS), Gap19 (100 
PM) or Gap27 (300 PM), scramble Gap27 (300 PM), or a mixture of 10panx1 and Gap19 
for 30 min. *, p < 0.05; **, p < 0.01; ***, p < 0.001, estimated from three independent 
experiments.  
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Figure 6. Signal transduction pathways in astrocyte migration activated by Thy-1 
receptors DVE3 integrin and Syndecan-4 
DVE3 integrin (receptor 1) engagement by Thy-1 is followed by intracellular signaling 
pathways that include activation of PI3K and PLCJ, IP3 production, IP3R activation in the 
ER, increase in cytosolic Ca2+, opening of hemichannels and subsequent ATP release, 
ATP-mediated P2X7R (receptor 2) activation, Ca2+ entry, PKCD activation, and Syndecan-
4 (receptor 3)-triggered signaling pathways that include activation of the Rho/ROCK axis 
with consequent changes in the actin cytoskeleton. Signaling pathways downstream of 
integrin, which include proteins forming FAs, also control the interplay between RhoA and 
Rac1 activation and actin remodeling [19]. 
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3. DISCUSSION 
Cell adhesion and migration are connected events; therefore, we predicted that the ATP-
induced P2X7R activation required for Thy-1-stimulated cell adhesion [20] should also 
control cell migration. In the present study, we show that ATP release requires the addition 
of Thy-1 with an intact integrin-binding site and that this ATP release occurs via a 
mechanism involving PI3K, PLCJ, IP3R activation, release of Ca2+ from the endoplasmic 
reticulum (ER), and ultimately Pannexin-1 and Connexin-43 hemichannel opening. 
Extracellular ATP, in turn, induces P2X7R activation, and the resulting influx of Ca2+ to 
the cell interior promotes astrocyte migration (Fig. 6). 
The P2X7R has been widely linked in the literature to cell inflammation and cell 
death, but the connections to cell migration are scarce. Moreover, existing reports 
concerning the effects of the P2X7R in cell migration are controversial. The P2X7R is 
reportedly necessary for corneal epithelium migration [56], whereas in fibroblasts, 
activation of this receptor blocks cell migration in a mitogen-associated protein kinase-
dependent manner [57]. In A549 human lung cancer cells, P2X7R activation induces cell 
migration [22], similar to that described for glioma cells [58], by activating Cathepsin B in 
a matrix metalloproteinase 9-dependent manner [59]. To the best of our knowledge, there 
are no reports concerning the relevance of P2X7Rs in astrocyte migration. Most 
importantly, the data presented herein uncovers a novel mechanism relevant to astrocyte 
migration, in which receptor transactivation mediated by both Connexin-43 and Pannexin-1 
hemichannels establishes a connection between integrin ligation and ATP-induced 
activation of P2X7Rs. 
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The controversy described for P2X7Rs in cell migration extends to the BzATP 
agonist, a pharmacological agent used to stimulate P2X7Rs for the study of cell migration 
[56-58]. BzATP has been shown to induce, as well as inhibit cell migration, depending on 
the concentration of the agonist used. BzATP enhances the migration of corneal epithelial 
cells [60] and C6 glioma cells [58] by activating P2X7R. In a different model, however, 
BzATP was shown to activate the adenosine receptors, P2X7R and A2A, preventing cell 
migration when used in low doses while causing the opposite effect when added at high 
concentrations [61]. Our previous studies showed that BzATP induces astrocyte adhesion 
[20], and here we show that BzATP also induces cell migration when concentrations are 
greater than 10 PM. Thus, in our model, BzATP alone is sufficient to mimic the effects of 
Thy-1-induced signaling downstream of DVE3 integrin and Syndecan-4 engagement [11, 
19]. A possible interpretation of these results is that continuous release of ATP is required 
to maintain high local ATP concentrations, which then activate P2X7R and the downstream 
signaling events required for cell migration. This interpretation would explain how BzATP, 
a non-hydrolyzable ATP analogue, might suffice to bypass DVE3 integrin and Syndecan-4 
engagement.  
Interestingly, Thy-1 mutated in the integrin-binding domain [Thy-1(RLE)-Fc], 
which can still bind to Syndecan-4, did not lead to ATP release, whereas Thy-1 mutated in 
the HBD [Thy-1(AEAAA)-Fc], which only possesses the integrin-binding site, increased 
extracellular ATP levels, albeit to a lesser extent and with delayed kinetics compared to 
wild-type Thy-1 (Fig. 2B). Importantly, neither of these mutated Thy-1 proteins 
individually stimulates cell adhesion or migration [11, 19]; however, the addition of low 
amounts of BzATP (<10 PM) with the Thy-1 mutant that binds Syndecan-4, suffices to 
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promote cell migration. An interesting possibility is that receptor transactivation involving 
integrin/ATP/P2X7R stimulation and Ca2+ influx further activates Syndecan-4 and 
downstream signal transduction pathways to promote the continuous ATP release that is 
required for cells to migrate. This is an intriguing hypothesis involving a feed-forward 
amplification mechanism that requires further investigation.  
Our results also show that the P2X7R-activating ATP is released from Thy-1-
stimulated astrocytes through both Connexin-43 and Pannexin-1 hemichannels. Several 
authors have described ATP release via connexins or pannexins, but evidence suggesting a 
requirement for both hemichannels in response to a single ligand is limited. ATP release 
through connexin and pannexin hemichannels has been reported in lung epithelium cells 
[62]. Additionally, in spinal cord or cerebral astrocytes, ATP release via both hemichannels 
reportedly also activates P2X7R in response to fibroblast growth factor (FGF) or ultrafine 
carbon black [32, 63]. Importantly though, Abudara and co-workers [32] used 
Carbexonolone to inhibit both connexins and pannexins simultaneously in spinal cord 
astrocytes and observed that FGF1 requires both hemichannels to release ATP after 7 h, 
whereas the increased permeability of the hemichannels detected after 2 h of FGF1 
treatment is mediated only by Pannexin-1. Importantly, here we show that the short-term 
response for cell adhesion (15 min), but not long-term cell migration (24 h), was 
completely prevented by blocking individual hemichannels (Fig. 5B, 5C compared with 
5E), whereas the combined inhibition of both hemichannels was necessary to reduce cell 
migration to control levels (Fig. 5E). These results argue that both hemichannels are 
necessary to activate signaling pathways required for long-term responses (hours), while 
short-term effects (minutes) involve individual hemichannels.  
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The present study provides evidence for the participation of hemichannel opening in 
Thy-1-induced astrocyte adhesion, polarization, and migration. The involvement of 
Connexin-43 in the migration of various cell types, including neuronal precursor cells, 
astrocytes, and cancer cells, has been reported [40, 41]. In astrocytes, Connexin-43 is 
necessary for astrocyte migration and proliferation but only upon injury to the central 
nervous system [40], and no connection between these events and neuron-derived factors 
has been reported. Alternatively, Pannexin-1 is required for the inflammatory response and 
the migration of cells from the immune system towards a chemo-attractant [42, 64]. In 
these experiments, Pannexin-1 was linked specifically to the cell migration that occurred 
during regeneration after injury-induced inflammation [42, 64]. However, whether 
Pannexin-1 plays a role in cell migration under non-inflammatory conditions is less clear, 
although some recently emerging evidence suggests that this is the case [43]. The results 
reported in our present study are novel in this sense because they describe how the neuronal 
protein, Thy-1, via integrin-dependent opening of Connexin-43 and Pannexin-1 
hemichannels, allows ATP release that, in turn, activates P2X7R. In doing so, this sequence 
of events links Thy-1-induced integrin signaling and astrocyte migration to P2X7R 
transactivation via ATP release. 
The additional data provided here demonstrate that Thy-1-induced hemichannel 
opening requires the release of intracellular Ca2+ from the ER through IP3R channels. 
Specifically, we show that PI3K and PLCJ activation lie upstream of ATP release induced 
by Thy-1-DVE3 integrin-binding. Additionally, our previous results implicate PLCJ in Thy-
1-induced RhoA activation and astrocyte adhesion [20]. We have also reported that PI3K 
activation occurs downstream of DVE3 integrin/FAK autophosphorylation [19]. By 
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assessing Akt phosphorylation as an indirect indicator of PI3K activation, we observed that 
Thy-1 containing the integrin-binding site but lacking the region for Syndecan-4-binding 
increased phosphorylation of Akt and that this event was precluded by the PI3K inhibitor, 
LY294002 [19]. Importantly, active PI3K increases levels of phosphatidylinositol 3,4,5-
trisphosphate at the plasma membrane, providing sites for recruitment of PLCJ[65, 66]. 
Then, PLCJ activated downstream of the DVE3 integrin/FAK/PI3K signaling cascade 
increases IP3 levels to stimulate IP3Rs in the ER and increase intracellular [Ca2+].  
Reportedly, augmented cytosolic Ca2+ is necessary for hemichannel opening. 
Connexin-43 hemichannels alter their permeability in response to changes in intracellular 
Ca2+ levels by either direct binding of Ca2+ to the hemichannel or via Ca2+/calmodulin-
dependent activation [55, 67]. Additionally, cytosolic Ca2+ has been reported to induce 
Pannexin-1 opening [68], whereas low extracellular Ca2+ concentrations increase the 
binding and activity of the P2X7R-Pannexin-1 complex [69]. Moreover, Ca2+ activates 
Ca2+/calmodulin-dependent kinases and/or conventional PKCs that, like calmodulin, 
modify hemichannel function [70, 71]. However, the details of the molecular mechanisms 
by which enhanced [Ca2+]i might regulate hemichannel opening upon stimulation of 
astrocytes with Thy-1 remain to be defined. 
Our recently reported data indicate that Thy-1-induced cell adhesion, polarization, 
and migration require the interaction of Thy-1 not only with DVE3 integrin, but also with 
Syndecan-4 [11, 19]. Interestingly, Syndecan-4 has been suggested to form a complex with 
PKCD to further activate RhoA and promote morphological changes and cell adhesion [11, 
72, 73]. Given that the activation of this conventional PKC isoform depends on calcium 
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[74] and that integrin engagement is followed by ATP/P2X7R-mediated Ca2+ influx into 
the cytosol [20], PKCD may be activated as a consequence of such Ca2+ entry (Fig. 6). 
Indeed, PKCD membrane translocation, an important step for PKC activation, via P2X7R-
induced Ca2+ elevation has been reported in osteoclasts [75]. Importantly, to form a 
complex with Syndecan-4, PKCD must translocate to the plasma membrane [73]. Thus, the 
activation of PKCD in a canonical manner, downstream of integrin/P2X7R, could generate 
a transient membrane-bound pool of PKCD required to form stable complexes with 
Syndecan-4 (Fig. 6). Taken together, our results indicate that, in astrocytes stimulated with 
Thy-1, integrin-dependent events might be activated prior to those triggered by Syndecan-4 
in a sequential manner. It should be noted that the cells utilized in the present study also 
express Syndecan-1 [11], which is implicated in cell migration [76]. The focus on 
Syndecan-4 was driven by our previous results implicating Syndecan-4 and PKCD in 
adhesion and migration [11, 19]. Moreover, the Syndecan-4 interactome is considerably 
more complex than the Syndecan-1 interactome due to the formation of a ternary complex 
between Syndecan-4, PIP2, and PKCD[77]. Therefore, we interpreted the participation of 
PKCD in our system as indicative of a prevalent role for Syndecan-4 rather than Syndecan-
1 in astrocyte migration. Nonetheless, Syndecan-1 participation in astrocyte migration 
cannot be ruled out. 
In summary, we suggest a receptor transactivation sequence (Fig. 6), whereby DVE3 
integrin (receptor 1) engagement is followed by the activation of a complex signaling 
sequence that includes PI3K and PLCJ activation, IP3 production, IP3R activation, an 
increase in cytosolic Ca2+, opening of hemichannels and subsequent ATP release, ATP-
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mediated P2X7R (receptor 2) activation, Ca2+ entry, PKCD activation, and Syndecan-4 
(receptor 3)-triggered signaling pathways. 
4. MATERIALS AND METHODS 
4.1. Culture of DITNC1 cells 
The DITNC1 astrocyte cell line (ATCC, CRL-2005) was originally obtained from primary 
cultures of rat diencephalons. Astrocytes were cultured in RPMI medium (Gibco, Life 
Technologies, Grand Island, NY) with 5% fetal bovine serum (FBS), 0.1 mM 2-
mercaptoethanol, 100 U/ml penicillin, and 100 Pg/ml streptomycin (complete medium). 
4.2. Thy-1-Fc and Trail-R2-Fc preparation  
Thy-1-Fc (wild-type and mutants) and Trail-R2-Fc fusion proteins were obtained as 
described previously [11, 14]. Proteins (2 µg/lane) were separated by SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) under non-reducing conditions and stained with 
Coomassie Brilliant blue. Thy-1-Fc and Trail-R2-Fc proteins were incubated with Protein 
A in a 10:1 ratio with gentle rotation for 1 h at 4ºC prior to their use. Astrocyte stimulation 
was performed by adding 1 Pg of fusion protein per 50,000 cells [13]. Trail-R2-Fc is a 
fusion protein of the receptor for the soluble apoptosis-inducing ligand, Trail [78], and it is 
used in these assays as a negative control for possible side effects caused by the Fc portion 
of the Thy-1 fusion proteins. 
4.3. Wound-healing assay 
DITNC1 cells were seeded in 24-well plates (100,000 cells per well), and after 24 h, two 
parallel wounds were introduced with a micropipette tip. Detached cells were washed away, 
AC
CE
PT
ED
 M
AN
US
CR
IPT
ACCEPTED MANUSCRIPT
  
 36 
and after 30 min of starvation, cells were stimulated with 4 Pg of either Thy-1-Fc or Trail-
R2-Fc (negative control) for 24 h; both proteins were coupled to Protein A as indicated 
above. The effect of the Thy-1-Fc mutants was tested either separately or in combination by 
adding both Thy-1(RLE)-Fc and Thy-1(AEAAA)-Fc to the Protein A coupling mix. 
Alternatively, migration was evaluated after treating the cells with various concentrations 
of BzATP in serum-free medium for 24 h with or without mutated Thy-1 proteins. Where 
indicated, BBG (5 PM), A438079 (100 nM), and Apyrase (3 U/ml), Probenecid (1 mM), 
Heptanol (500 PM), Gap19 (100 PM), Gap27 (300 PM), or scrambled peptide (300 PM) 
were added 30 min prior to stimulation and left for the next 24 h. These experiments were 
also performed using DITNC1 cells transiently transfected with specific siRNA against 
P2X7R (Dharmacon, Lafayette, CO) or the indicated negative siRNA control using the 
siPORT Amine transfection reagent (Ambion, Thermo Fischer Scientific, Rockford, IL) as 
previously reported [20]. Images used to quantify the cell-free area were obtained at 0 and 
24 h as described [19]. 
4.4. Polarity assay 
Astrocytes were seeded on 12-mm coverslips (50,000 cells per coverslip), prepared and 
treated as for wound-healing assays, but were stimulated with Protein A-conjugated Thy-1-
Fc, Trail-R2-Fc, or 100 PM BzATP for 7 h. Astrocytes were then fixed for 10 min with 4% 
paraformaldehyde, permeabilized, and blocked as described previously [45]. Cells were 
then incubated at 37ºC with anti-giantin antibody (Covance Research Products, Denver, 
PA) for 1 h, followed by secondary antibody coupled to FITC (Jackson ImmunoResearch 
Laboratories, Inc, West Grove, PA) and Rhodamine-conjugated Phalloidin (Sigma-Aldrich 
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Co., Saint Louis, MO) for 1 h to stain for F-actin. DAPI (0.025 Pg/ml) was used to stain the 
nucleus. Coverslips were mounted on slides as described previously [19], and samples were 
observed using a Disk Scanning Unit-IX81 Spinning disk confocal microscope (Olympus 
Corp.). Cells were considered polarized when the Golgi apparatus was located in the 
perinuclear area and oriented towards the cell-free zone within a 120º angle (see scheme in 
Fig. 1C). DITNC1 cells were stimulated as described previously [19]. One hundred cells 
were monitored per condition, and cell polarization was evaluated as the percentage of cells 
along the wound border exhibiting polarized Golgi structures [45].  
4.5. Extracellular ATP measurements 
DITNC1 astrocytes (50,000) in 50 Pl were left in serum-free media containing 100 PM of 
the exonuclease inhibitor, Ebselen, for 30 min at 37ºC. Before stimulation with Thy-1-
Fc:Protein A (10 min or as indicated for kinetic analyses) where indicated, cells were 
incubated with Heptanol (500 PM), Probenecid (1 mM), or a combination of both 
inhibitors; the exocytosis inhibitors, Brefeldine A (3 Pg/ml for 4 h) or Bafilomycin A (1 
PM for 4 h); the hemichannel-blocking peptides, 10panx1 (100 PM), E1B (100 PM), Gap 
26 (300 PM), or Gap27 (300 PM), for 30 min; the IP3R blockers, 2-APB (5 PM for 1 h) or 
Xestospongine B (5 PM for 4 h); Ryanodine (50 PM for 4 h); BAPTA-AM (5 PM for 1 h); 
U73122 (10 PM for 30 min); or LY294002 (10 PM for 1 h). Afterwards, cells were 
centrifuged for 5 min at 800 u g. The supernatants were then incubated in the dark with 20 
Pl of the CellTiter-Glo (Promega, Madison, WI) reaction mix for 40 min. Luminescence 
intensity was determined in a Synergy2 multi-mode reader (Biotek Instruments, Inc., 
Vermont), and the values were interpolated using a calibration curve obtained with 
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different ATP concentrations (0.01, 0.1, 1, and 10 PM). Furthermore, these experiments 
also included DITNC1 cells transiently transfected with specific siRNA against Syndecan-4 
(Ambion), E3 integrin (Ambion), or the indicated negative siRNA control using the Amaxa 
Nucleofector system (Lonza, Cologne, Germany). 
4.6. Lucifer Yellow uptake 
DITNC1 astrocytes (400,000 cells) were seeded on 25-mm coverslips and left to adhere for 
24 h. Cells were then treated with the indicated inhibitors (as for ATP measurements) prior 
to stimulating with Thy-1-Fc or Trail-R2-Fc coupled to Protein A for 10 min. After 
stimulation, the cells were incubated at 37ºC with 0.5 mg/ml Lucifer Yellow in Ringer 
Solution (155 mM NaCl, 4.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 5 
mM Hepes pH 7.4) for 10 min and then washed twice with the same solution. Lucifer 
Yellow fluorescence intensity was quantified in 100 cells per condition in relative units, 
using the region of interest (ROI) plug-in in the ImageJ software (National Institutes of 
Health, Bethesda, MD, http://imagej.nih.gov/ij/). The probe was excited at 458 nm, and 
emission between 500-530 nm was quantified.  
4.7. Western blot analysis  
Protein extracts were prepared in lysis buffer (150 mM NaCl, 0.1% SDS, 0.25% sodium 
deoxycholate, 1% Triton-X100, and 50 mM Tris pH 7.4,) supplemented with protease and 
phosphatase inhibitor cocktails (Biotool, Houston, TX). Extracts were electrophoretically 
separated in 10% SDS-PAGE gels and transferred to nitrocellulose (Millipore, Billerica, 
USA). The nitrocellulose was blocked with 5% w/v nonfat, dry milk in PBS containing 
0.1% Tween-20 and then incubated with the primary antibodies: anti-Connexin-43 (1:500; 
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Santa Cruz Biotechnologies Dallas, TX) or anti-Pannexin-1 (1:500; Santa Cruz 
Biotechnologies). The membrane was then washed and incubated with the horseradish 
peroxidase-conjugated goat anti-rabbit IgG (1:5000; Abbexa, Cambridge, UK) or donkey 
anti-goat IgG (1:5000; Abbexa) antibodies for 1 h at room temperature. Bands were 
visualized with a chemiluminescence kit (Pierce, Thermo Scientific, Rockford, IL), 
according  to  the  manufacturer’s  instructions. 
4.8. Measurement of intracellular calcium kinetics  
Astrocytes were seeded on 25-mm coverslips (400,000 cells) and left to adhere for 24 h. 
The cells were then incubated for 40 min with 5 PM Fluo-4-AM in Ringer solution at 37ºC. 
The cells were washed and left in the same solution. Astrocytes were treated with the 
hemichannel blockers, Heptanol (500 PM), Probenecid (1 mM), or a mixture of both 
inhibitors for 30 min; the IP3R blockers, 2-APB (5 PM for 1 h) or Xestospongine B (5 PM 
for 4 h); Ryanodine (50 PM for 4 h); or BAPTA-AM (5 PM for 1 h). Images were acquired 
at 2-second intervals with an XM10 camera (Olympus Corp.). Thy-1-Fc or Trail-R2-Fc, 
both coupled to Protein A, were added after 40 s, and the fluorescence was recorded for 15 
min. Fluorescence intensity was quantified in 100 cells per condition using ImageJ. The 
results were expressed as (F-F0)/F0, where F is the change in fluorescence and F0 is the 
basal fluorescence. 
4.9. Focal adhesion assay 
DITNC1 cells were seeded on 12-mm coverslips and left to adhere for 24 h. The cells were 
then pre-treated with the hemichannel blockers, Heptanol (500 PM), Probenecid (1 mM), or 
a combination of both inhibitors for 30 min and stimulated with Thy-1-Fc-Protein A or the 
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control protein for 15 min. Astrocytes were then washed and fixed for 10 min with 4% 
paraformaldehyde, permeabilized for 10 min, and blocked for 1 h with 2% bovine serum 
albumin (BSA). The cells were then incubated with antibodies for 1 h at 37ºC. Anti-
vinculin, rhodamine-conjugated Phalloidin, and DAPI (0.025 Pg/ml) were used to stain for 
focal adhesions, F-actin, and nuclei, respectively. Quantification of focal adhesion area and 
number was performed following previously described protocols [11]. 
4.10. Indirect immunofluorescence assay 
DITNC1 cells seeded on 12-mm coverslips and left to adhere for 24 h were then washed 
and fixed as indicated for the Focal adhesion assay. Afterward, cells were stained with anti-
Connexin-43 (1:200) or anti-Pannexin-1 (1:200) antibodies followed by secondary 
antibodies (1:500) conjugated to IF488 (green) or IF594 (red), respectively (Abbexa), and 
DAPI (0.025 Pg/ml) (blue). Samples were analyzed using a confocal microscope C2+ 
(Nikon), with 60X/1.40 objective and NIS-Elements software. 
4.11. Statistical analysis  
The results are shown as the means ± standard error of the mean (s.e.m.) for n = 3 or more 
experiments. The results were analyzed using one-way ANOVA tests and Tukey post-tests. 
Statistical significance was set at p < 0.05. 
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Graphical Abstract 
Highlights 
 Thy-1-DVE3 integrin binding triggers ATP release through astrocyte hemichannels 
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 Activation of hemichannels depends on a novel DVE3 integrin-PLCγ-IP3R pathway 
 Extracellular ATP mediates P2X7R integrin-dependent transactivation 
 P2X7R transactivation allows Ca+2 entry and astrocyte migration 
